These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 32290285)

  • 1. Hyaluronic Acid-Based Theranostic Nanomedicines for Targeted Cancer Therapy.
    Lee SY; Kang MS; Jeong WY; Han DW; Kim KS
    Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32290285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyaluronic Acid-Coated Nanomedicine for Targeted Cancer Therapy.
    Kim K; Choi H; Choi ES; Park MH; Ryu JH
    Pharmaceutics; 2019 Jun; 11(7):. PubMed ID: 31262049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyaluronic Acid-Based Nanocarriers for Anticancer Drug Delivery.
    Fu CP; Cai XY; Chen SL; Yu HW; Fang Y; Feng XC; Zhang LM; Li CY
    Polymers (Basel); 2023 May; 15(10):. PubMed ID: 37242892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent developments in hyaluronic acid-based nanomedicine for targeted cancer treatment.
    Rao NV; Yoon HY; Han HS; Ko H; Son S; Lee M; Lee H; Jo DG; Kang YM; Park JH
    Expert Opin Drug Deliv; 2016; 13(2):239-52. PubMed ID: 26653872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyaluronic Acid-Based Nanomaterials Applied to Cancer: Where Are We Now?
    Machado V; Morais M; Medeiros R
    Pharmaceutics; 2022 Sep; 14(10):. PubMed ID: 36297526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyaluronan-based Multifunctional Nano-carriers for Combination Cancer Therapy.
    Gao M; Deng H; Zhang W
    Curr Top Med Chem; 2021; 21(2):126-139. PubMed ID: 32962617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies for Hyaluronic Acid-Based Hydrogel Design in Drug Delivery.
    Trombino S; Servidio C; Curcio F; Cassano R
    Pharmaceutics; 2019 Aug; 11(8):. PubMed ID: 31408954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyaluronic acid and albumin based nanoparticles for drug delivery.
    Lei C; Liu XR; Chen QB; Li Y; Zhou JL; Zhou LY; Zou T
    J Control Release; 2021 Mar; 331():416-433. PubMed ID: 33503486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in hyaluronic acid-based nanomedicines: Preparation and application in cancer therapy.
    Hou X; Zhong D; Chen H; Gu Z; Gong Q; Ma X; Zhang H; Zhu H; Luo K
    Carbohydr Polym; 2022 Sep; 292():119662. PubMed ID: 35725165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Theranostic Hyaluronic Acid-Iron Micellar Nanoparticles for Magnetic-Field-Enhanced in vivo Cancer Chemotherapy.
    Wang G; Gao S; Tian R; Miller-Kleinhenz J; Qin Z; Liu T; Li L; Zhang F; Ma Q; Zhu L
    ChemMedChem; 2018 Jan; 13(1):78-86. PubMed ID: 29086481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticancer therapeutics: targeting macromolecules and nanocarriers to hyaluronan or CD44, a hyaluronan receptor.
    Platt VM; Szoka FC
    Mol Pharm; 2008; 5(4):474-86. PubMed ID: 18547053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyaluronic acid for anticancer drug and nucleic acid delivery.
    Dosio F; Arpicco S; Stella B; Fattal E
    Adv Drug Deliv Rev; 2016 Feb; 97():204-36. PubMed ID: 26592477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Facile fabrication of robust, hyaluronic acid-surfaced and disulfide-crosslinked PLGA nanoparticles for tumor-targeted and reduction-triggered release of docetaxel.
    Wang X; Cheng R; Zhong Z
    Acta Biomater; 2021 Apr; 125():280-289. PubMed ID: 33677162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyaluronic acid-based nano drug delivery systems for breast cancer treatment: Recent advances.
    Jia Y; Chen S; Wang C; Sun T; Yang L
    Front Bioeng Biotechnol; 2022; 10():990145. PubMed ID: 36091467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyaluronic acid-based prodrug nanomedicines for enhanced tumor targeting and therapy: A review.
    Zhang R; Zhao X; Jia A; Wang C; Jiang H
    Int J Biol Macromol; 2023 Sep; 249():125993. PubMed ID: 37506794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyaluronic acid-serum albumin conjugate-based nanoparticles for targeted cancer therapy.
    Edelman R; Assaraf YG; Levitzky I; Shahar T; Livney YD
    Oncotarget; 2017 Apr; 8(15):24337-24353. PubMed ID: 28212584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomedical Applications of Hyaluronic Acid-Based Nanomaterials in Hyperthermic Cancer Therapy.
    Kim S; Moon MJ; Poilil Surendran S; Jeong YY
    Pharmaceutics; 2019 Jul; 11(7):. PubMed ID: 31266194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One-pot preparation of hyaluronic acid-coated iron oxide nanoparticles for magnetic hyperthermia therapy and targeting CD44-overexpressing cancer cells.
    Soleymani M; Velashjerdi M; Shaterabadi Z; Barati A
    Carbohydr Polym; 2020 Jun; 237():116130. PubMed ID: 32241421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pursuing for the better lung cancer therapy effect: Comparison of two different kinds of hyaluronic acid and nitroimidazole co-decorated nanomedicines.
    Chen G; Zhang Y; Deng H; Tang Z; Mao J; Wang L
    Biomed Pharmacother; 2020 May; 125():109988. PubMed ID: 32059173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.